Request for Covid-19 Impact Assessment of this Report
The United States Injectable Sumatriptan market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Injectable Sumatriptan market, reaching US$ million by the year 2028. As for the Europe Injectable Sumatriptan landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Injectable Sumatriptan players cover GlaxoSmithKline, Pfizer, Teva, and Sun Pharma, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Injectable Sumatriptan market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
4mg
6mg
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospitals
Clinics
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
GlaxoSmithKline
Pfizer
Teva
Sun Pharma
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Injectable Sumatriptan Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Injectable Sumatriptan by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Injectable Sumatriptan by Country/Region, 2017, 2022 & 2028
2.2 Injectable Sumatriptan Segment by Type
2.2.1 4mg
2.2.2 6mg
2.2.3 Others
2.3 Injectable Sumatriptan Sales by Type
2.3.1 Global Injectable Sumatriptan Sales Market Share by Type (2017-2022)
2.3.2 Global Injectable Sumatriptan Revenue and Market Share by Type (2017-2022)
2.3.3 Global Injectable Sumatriptan Sale Price by Type (2017-2022)
2.4 Injectable Sumatriptan Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Others
2.5 Injectable Sumatriptan Sales by Application
2.5.1 Global Injectable Sumatriptan Sale Market Share by Application (2017-2022)
2.5.2 Global Injectable Sumatriptan Revenue and Market Share by Application (2017-2022)
2.5.3 Global Injectable Sumatriptan Sale Price by Application (2017-2022)
3 Global Injectable Sumatriptan by Company
3.1 Global Injectable Sumatriptan Breakdown Data by Company
3.1.1 Global Injectable Sumatriptan Annual Sales by Company (2020-2022)
3.1.2 Global Injectable Sumatriptan Sales Market Share by Company (2020-2022)
3.2 Global Injectable Sumatriptan Annual Revenue by Company (2020-2022)
3.2.1 Global Injectable Sumatriptan Revenue by Company (2020-2022)
3.2.2 Global Injectable Sumatriptan Revenue Market Share by Company (2020-2022)
3.3 Global Injectable Sumatriptan Sale Price by Company
3.4 Key Manufacturers Injectable Sumatriptan Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Injectable Sumatriptan Product Location Distribution
3.4.2 Players Injectable Sumatriptan Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Injectable Sumatriptan by Geographic Region
4.1 World Historic Injectable Sumatriptan Market Size by Geographic Region (2017-2022)
4.1.1 Global Injectable Sumatriptan Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Injectable Sumatriptan Annual Revenue by Geographic Region
4.2 World Historic Injectable Sumatriptan Market Size by Country/Region (2017-2022)
4.2.1 Global Injectable Sumatriptan Annual Sales by Country/Region (2017-2022)
4.2.2 Global Injectable Sumatriptan Annual Revenue by Country/Region
4.3 Americas Injectable Sumatriptan Sales Growth
4.4 APAC Injectable Sumatriptan Sales Growth
4.5 Europe Injectable Sumatriptan Sales Growth
4.6 Middle East & Africa Injectable Sumatriptan Sales Growth
5 Americas
5.1 Americas Injectable Sumatriptan Sales by Country
5.1.1 Americas Injectable Sumatriptan Sales by Country (2017-2022)
5.1.2 Americas Injectable Sumatriptan Revenue by Country (2017-2022)
5.2 Americas Injectable Sumatriptan Sales by Type
5.3 Americas Injectable Sumatriptan Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Injectable Sumatriptan Sales by Region
6.1.1 APAC Injectable Sumatriptan Sales by Region (2017-2022)
6.1.2 APAC Injectable Sumatriptan Revenue by Region (2017-2022)
6.2 APAC Injectable Sumatriptan Sales by Type
6.3 APAC Injectable Sumatriptan Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Injectable Sumatriptan by Country
7.1.1 Europe Injectable Sumatriptan Sales by Country (2017-2022)
7.1.2 Europe Injectable Sumatriptan Revenue by Country (2017-2022)
7.2 Europe Injectable Sumatriptan Sales by Type
7.3 Europe Injectable Sumatriptan Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Injectable Sumatriptan by Country
8.1.1 Middle East & Africa Injectable Sumatriptan Sales by Country (2017-2022)
8.1.2 Middle East & Africa Injectable Sumatriptan Revenue by Country (2017-2022)
8.2 Middle East & Africa Injectable Sumatriptan Sales by Type
8.3 Middle East & Africa Injectable Sumatriptan Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Injectable Sumatriptan
10.3 Manufacturing Process Analysis of Injectable Sumatriptan
10.4 Industry Chain Structure of Injectable Sumatriptan
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Injectable Sumatriptan Distributors
11.3 Injectable Sumatriptan Customer
12 World Forecast Review for Injectable Sumatriptan by Geographic Region
12.1 Global Injectable Sumatriptan Market Size Forecast by Region
12.1.1 Global Injectable Sumatriptan Forecast by Region (2023-2028)
12.1.2 Global Injectable Sumatriptan Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Injectable Sumatriptan Forecast by Type
12.7 Global Injectable Sumatriptan Forecast by Application
13 Key Players Analysis
13.1 GlaxoSmithKline
13.1.1 GlaxoSmithKline Company Information
13.1.2 GlaxoSmithKline Injectable Sumatriptan Product Offered
13.1.3 GlaxoSmithKline Injectable Sumatriptan Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 GlaxoSmithKline Main Business Overview
13.1.5 GlaxoSmithKline Latest Developments
13.2 Pfizer
13.2.1 Pfizer Company Information
13.2.2 Pfizer Injectable Sumatriptan Product Offered
13.2.3 Pfizer Injectable Sumatriptan Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Pfizer Main Business Overview
13.2.5 Pfizer Latest Developments
13.3 Teva
13.3.1 Teva Company Information
13.3.2 Teva Injectable Sumatriptan Product Offered
13.3.3 Teva Injectable Sumatriptan Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Teva Main Business Overview
13.3.5 Teva Latest Developments
13.4 Sun Pharma
13.4.1 Sun Pharma Company Information
13.4.2 Sun Pharma Injectable Sumatriptan Product Offered
13.4.3 Sun Pharma Injectable Sumatriptan Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Sun Pharma Main Business Overview
13.4.5 Sun Pharma Latest Developments
14 Research Findings and Conclusion
Table 1. Injectable Sumatriptan Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Injectable Sumatriptan Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 4mg
Table 4. Major Players of 6mg
Table 5. Major Players of Others
Table 6. Global Injectable Sumatriptan Sales by Type (2017-2022) & (K Units)
Table 7. Global Injectable Sumatriptan Sales Market Share by Type (2017-2022)
Table 8. Global Injectable Sumatriptan Revenue by Type (2017-2022) & ($ million)
Table 9. Global Injectable Sumatriptan Revenue Market Share by Type (2017-2022)
Table 10. Global Injectable Sumatriptan Sale Price by Type (2017-2022) & (US$/Unit)
Table 11. Global Injectable Sumatriptan Sales by Application (2017-2022) & (K Units)
Table 12. Global Injectable Sumatriptan Sales Market Share by Application (2017-2022)
Table 13. Global Injectable Sumatriptan Revenue by Application (2017-2022)
Table 14. Global Injectable Sumatriptan Revenue Market Share by Application (2017-2022)
Table 15. Global Injectable Sumatriptan Sale Price by Application (2017-2022) & (US$/Unit)
Table 16. Global Injectable Sumatriptan Sales by Company (2020-2022) & (K Units)
Table 17. Global Injectable Sumatriptan Sales Market Share by Company (2020-2022)
Table 18. Global Injectable Sumatriptan Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Injectable Sumatriptan Revenue Market Share by Company (2020-2022)
Table 20. Global Injectable Sumatriptan Sale Price by Company (2020-2022) & (US$/Unit)
Table 21. Key Manufacturers Injectable Sumatriptan Producing Area Distribution and Sales Area
Table 22. Players Injectable Sumatriptan Products Offered
Table 23. Injectable Sumatriptan Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Injectable Sumatriptan Sales by Geographic Region (2017-2022) & (K Units)
Table 27. Global Injectable Sumatriptan Sales Market Share Geographic Region (2017-2022)
Table 28. Global Injectable Sumatriptan Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Injectable Sumatriptan Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Injectable Sumatriptan Sales by Country/Region (2017-2022) & (K Units)
Table 31. Global Injectable Sumatriptan Sales Market Share by Country/Region (2017-2022)
Table 32. Global Injectable Sumatriptan Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Injectable Sumatriptan Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Injectable Sumatriptan Sales by Country (2017-2022) & (K Units)
Table 35. Americas Injectable Sumatriptan Sales Market Share by Country (2017-2022)
Table 36. Americas Injectable Sumatriptan Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Injectable Sumatriptan Revenue Market Share by Country (2017-2022)
Table 38. Americas Injectable Sumatriptan Sales by Type (2017-2022) & (K Units)
Table 39. Americas Injectable Sumatriptan Sales Market Share by Type (2017-2022)
Table 40. Americas Injectable Sumatriptan Sales by Application (2017-2022) & (K Units)
Table 41. Americas Injectable Sumatriptan Sales Market Share by Application (2017-2022)
Table 42. APAC Injectable Sumatriptan Sales by Region (2017-2022) & (K Units)
Table 43. APAC Injectable Sumatriptan Sales Market Share by Region (2017-2022)
Table 44. APAC Injectable Sumatriptan Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Injectable Sumatriptan Revenue Market Share by Region (2017-2022)
Table 46. APAC Injectable Sumatriptan Sales by Type (2017-2022) & (K Units)
Table 47. APAC Injectable Sumatriptan Sales Market Share by Type (2017-2022)
Table 48. APAC Injectable Sumatriptan Sales by Application (2017-2022) & (K Units)
Table 49. APAC Injectable Sumatriptan Sales Market Share by Application (2017-2022)
Table 50. Europe Injectable Sumatriptan Sales by Country (2017-2022) & (K Units)
Table 51. Europe Injectable Sumatriptan Sales Market Share by Country (2017-2022)
Table 52. Europe Injectable Sumatriptan Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Injectable Sumatriptan Revenue Market Share by Country (2017-2022)
Table 54. Europe Injectable Sumatriptan Sales by Type (2017-2022) & (K Units)
Table 55. Europe Injectable Sumatriptan Sales Market Share by Type (2017-2022)
Table 56. Europe Injectable Sumatriptan Sales by Application (2017-2022) & (K Units)
Table 57. Europe Injectable Sumatriptan Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Injectable Sumatriptan Sales by Country (2017-2022) & (K Units)
Table 59. Middle East & Africa Injectable Sumatriptan Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Injectable Sumatriptan Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Injectable Sumatriptan Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Injectable Sumatriptan Sales by Type (2017-2022) & (K Units)
Table 63. Middle East & Africa Injectable Sumatriptan Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Injectable Sumatriptan Sales by Application (2017-2022) & (K Units)
Table 65. Middle East & Africa Injectable Sumatriptan Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Injectable Sumatriptan
Table 67. Key Market Challenges & Risks of Injectable Sumatriptan
Table 68. Key Industry Trends of Injectable Sumatriptan
Table 69. Injectable Sumatriptan Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Injectable Sumatriptan Distributors List
Table 72. Injectable Sumatriptan Customer List
Table 73. Global Injectable Sumatriptan Sales Forecast by Region (2023-2028) & (K Units)
Table 74. Global Injectable Sumatriptan Sales Market Forecast by Region
Table 75. Global Injectable Sumatriptan Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Injectable Sumatriptan Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Injectable Sumatriptan Sales Forecast by Country (2023-2028) & (K Units)
Table 78. Americas Injectable Sumatriptan Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Injectable Sumatriptan Sales Forecast by Region (2023-2028) & (K Units)
Table 80. APAC Injectable Sumatriptan Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Injectable Sumatriptan Sales Forecast by Country (2023-2028) & (K Units)
Table 82. Europe Injectable Sumatriptan Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Injectable Sumatriptan Sales Forecast by Country (2023-2028) & (K Units)
Table 84. Middle East & Africa Injectable Sumatriptan Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Injectable Sumatriptan Sales Forecast by Type (2023-2028) & (K Units)
Table 86. Global Injectable Sumatriptan Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Injectable Sumatriptan Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Injectable Sumatriptan Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Injectable Sumatriptan Sales Forecast by Application (2023-2028) & (K Units)
Table 90. Global Injectable Sumatriptan Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Injectable Sumatriptan Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Injectable Sumatriptan Revenue Market Share Forecast by Application (2023-2028)
Table 93. GlaxoSmithKline Basic Information, Injectable Sumatriptan Manufacturing Base, Sales Area and Its Competitors
Table 94. GlaxoSmithKline Injectable Sumatriptan Product Offered
Table 95. GlaxoSmithKline Injectable Sumatriptan Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 96. GlaxoSmithKline Main Business
Table 97. GlaxoSmithKline Latest Developments
Table 98. Pfizer Basic Information, Injectable Sumatriptan Manufacturing Base, Sales Area and Its Competitors
Table 99. Pfizer Injectable Sumatriptan Product Offered
Table 100. Pfizer Injectable Sumatriptan Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 101. Pfizer Main Business
Table 102. Pfizer Latest Developments
Table 103. Teva Basic Information, Injectable Sumatriptan Manufacturing Base, Sales Area and Its Competitors
Table 104. Teva Injectable Sumatriptan Product Offered
Table 105. Teva Injectable Sumatriptan Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 106. Teva Main Business
Table 107. Teva Latest Developments
Table 108. Sun Pharma Basic Information, Injectable Sumatriptan Manufacturing Base, Sales Area and Its Competitors
Table 109. Sun Pharma Injectable Sumatriptan Product Offered
Table 110. Sun Pharma Injectable Sumatriptan Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 111. Sun Pharma Main Business
Table 112. Sun Pharma Latest Developments
List of Figures
Figure 1. Picture of Injectable Sumatriptan
Figure 2. Injectable Sumatriptan Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Injectable Sumatriptan Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Injectable Sumatriptan Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Injectable Sumatriptan Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 4mg
Figure 10. Product Picture of 6mg
Figure 11. Product Picture of Others
Figure 12. Global Injectable Sumatriptan Sales Market Share by Type in 2021
Figure 13. Global Injectable Sumatriptan Revenue Market Share by Type (2017-2022)
Figure 14. Injectable Sumatriptan Consumed in Hospitals
Figure 15. Global Injectable Sumatriptan Market: Hospitals (2017-2022) & (K Units)
Figure 16. Injectable Sumatriptan Consumed in Clinics
Figure 17. Global Injectable Sumatriptan Market: Clinics (2017-2022) & (K Units)
Figure 18. Injectable Sumatriptan Consumed in Others
Figure 19. Global Injectable Sumatriptan Market: Others (2017-2022) & (K Units)
Figure 20. Global Injectable Sumatriptan Sales Market Share by Application (2017-2022)
Figure 21. Global Injectable Sumatriptan Revenue Market Share by Application in 2021
Figure 22. Injectable Sumatriptan Revenue Market by Company in 2021 ($ Million)
Figure 23. Global Injectable Sumatriptan Revenue Market Share by Company in 2021
Figure 24. Global Injectable Sumatriptan Sales Market Share by Geographic Region (2017-2022)
Figure 25. Global Injectable Sumatriptan Revenue Market Share by Geographic Region in 2021
Figure 26. Global Injectable Sumatriptan Sales Market Share by Region (2017-2022)
Figure 27. Global Injectable Sumatriptan Revenue Market Share by Country/Region in 2021
Figure 28. Americas Injectable Sumatriptan Sales 2017-2022 (K Units)
Figure 29. Americas Injectable Sumatriptan Revenue 2017-2022 ($ Millions)
Figure 30. APAC Injectable Sumatriptan Sales 2017-2022 (K Units)
Figure 31. APAC Injectable Sumatriptan Revenue 2017-2022 ($ Millions)
Figure 32. Europe Injectable Sumatriptan Sales 2017-2022 (K Units)
Figure 33. Europe Injectable Sumatriptan Revenue 2017-2022 ($ Millions)
Figure 34. Middle East & Africa Injectable Sumatriptan Sales 2017-2022 (K Units)
Figure 35. Middle East & Africa Injectable Sumatriptan Revenue 2017-2022 ($ Millions)
Figure 36. Americas Injectable Sumatriptan Sales Market Share by Country in 2021
Figure 37. Americas Injectable Sumatriptan Revenue Market Share by Country in 2021
Figure 38. United States Injectable Sumatriptan Revenue Growth 2017-2022 ($ Millions)
Figure 39. Canada Injectable Sumatriptan Revenue Growth 2017-2022 ($ Millions)
Figure 40. Mexico Injectable Sumatriptan Revenue Growth 2017-2022 ($ Millions)
Figure 41. Brazil Injectable Sumatriptan Revenue Growth 2017-2022 ($ Millions)
Figure 42. APAC Injectable Sumatriptan Sales Market Share by Region in 2021
Figure 43. APAC Injectable Sumatriptan Revenue Market Share by Regions in 2021
Figure 44. China Injectable Sumatriptan Revenue Growth 2017-2022 ($ Millions)
Figure 45. Japan Injectable Sumatriptan Revenue Growth 2017-2022 ($ Millions)
Figure 46. South Korea Injectable Sumatriptan Revenue Growth 2017-2022 ($ Millions)
Figure 47. Southeast Asia Injectable Sumatriptan Revenue Growth 2017-2022 ($ Millions)
Figure 48. India Injectable Sumatriptan Revenue Growth 2017-2022 ($ Millions)
Figure 49. Australia Injectable Sumatriptan Revenue Growth 2017-2022 ($ Millions)
Figure 50. Europe Injectable Sumatriptan Sales Market Share by Country in 2021
Figure 51. Europe Injectable Sumatriptan Revenue Market Share by Country in 2021
Figure 52. Germany Injectable Sumatriptan Revenue Growth 2017-2022 ($ Millions)
Figure 53. France Injectable Sumatriptan Revenue Growth 2017-2022 ($ Millions)
Figure 54. UK Injectable Sumatriptan Revenue Growth 2017-2022 ($ Millions)
Figure 55. Italy Injectable Sumatriptan Revenue Growth 2017-2022 ($ Millions)
Figure 56. Russia Injectable Sumatriptan Revenue Growth 2017-2022 ($ Millions)
Figure 57. Middle East & Africa Injectable Sumatriptan Sales Market Share by Country in 2021
Figure 58. Middle East & Africa Injectable Sumatriptan Revenue Market Share by Country in 2021
Figure 59. Egypt Injectable Sumatriptan Revenue Growth 2017-2022 ($ Millions)
Figure 60. South Africa Injectable Sumatriptan Revenue Growth 2017-2022 ($ Millions)
Figure 61. Israel Injectable Sumatriptan Revenue Growth 2017-2022 ($ Millions)
Figure 62. Turkey Injectable Sumatriptan Revenue Growth 2017-2022 ($ Millions)
Figure 63. GCC Country Injectable Sumatriptan Revenue Growth 2017-2022 ($ Millions)
Figure 64. Manufacturing Cost Structure Analysis of Injectable Sumatriptan in 2021
Figure 65. Manufacturing Process Analysis of Injectable Sumatriptan
Figure 66. Industry Chain Structure of Injectable Sumatriptan
Figure 67. Channels of Distribution
Figure 68. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...